DL-Lysine ((±)-2,6-Diaminocaproic acid)
(Synonyms: DL-赖氨酸; (±)-2,6-Diaminocaproic acid) 目录号 : GC30236DL-赖氨酸 ((±)-2,6-Diaminocaproic acid) 是 D-赖氨酸和 L-赖氨酸的外消旋混合物。
Cas No.:70-54-2
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
DL-Lysine (Lysine) is an α-amino acid that is used in the biosynthesis of proteins.
DL-Lysine (Lys) is a high affinity, basic amino acid substrate for amino acid transporter b0,+ with Km value ranging from 100-400 μM[1].
[1]. Nguyen TV, et al. PEPT1 enhances the uptake of gabapentin via trans-stimulation of b0,+ exchange. Pharm Res. 2007 Feb;24(2):353-60.
Cas No. | 70-54-2 | SDF | |
别名 | DL-赖氨酸; (±)-2,6-Diaminocaproic acid | ||
Canonical SMILES | NC(CCCCN)C(O)=O | ||
分子式 | C6H14N2O2 | 分子量 | 146.19 |
溶解度 | Water : ≥ 150 mg/mL (1026.06 mM) | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 6.8404 mL | 34.2021 mL | 68.4041 mL |
5 mM | 1.3681 mL | 6.8404 mL | 13.6808 mL |
10 mM | 0.684 mL | 3.4202 mL | 6.8404 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
DL-LYSINE (monochloride)
SYNTHESIS OF N6,N6-BIS(2-CHLOROETHYL)-DL-LYSINE
The availability of in-acetyl-d-lysine and in-methyl-dl-lysine for growth
Potential inhibitors of collagen biosynthesis. 5,5-Difluoro-DL-lysine and 5,5-dimethyl-DL-lysine and their activation by lysyl-tRNA ligase
The synthesis of lysine analogues wherein blocking groups are substituted at position 5, the site of hydroxylation by peptidyl lysine hydroxylase, is described. Thus, 5,5-difluorolysine (1) and 5,5-dimethylysine (2) were synthesized via a four- and six-step sequence, respectively, starting from ketone precursors. The propensity for these lysine analogues to be incorporated into procollagen protein in vivo was assessed by their ability to stimulate the lysine-dependent ATP-PPi exchange reaction in the presence of lysyl-tRNA ligase in vitro. The difluoro analogue 1 stimulated exchange, but at a Km (1.3 X 10(-3) M) 1000 times greater than that for lysine itself. The dimethyl analogue 2 did not stimulate exchange, but at high concentrations was a competitive inhibitor of lysine, with an apparent Ki of 1.6 X 10(-2) M. Thus, electronegative and/or bulky substituents at the 5 position of lysine cannot be tolerated by lysyl-tRNA ligase, and this position must be kept free in lysine analogues specifically designed to block collagen biosynthesis.
Preparation of L- and D-[1-14C]lysine by the resolution of DL-[1-14 C]lysine
L-[1-14C]lysine was prepared using a technique based on the differential solubility of the diastereomeric salts of DL-lysine with L-glutamic acid. D-[1-14C]lysine was prepared by the enzymatic removal of residual L-[1-14C]lysine from the reaction mixture remaining after the preparation of L-[1-14C]lysine. The products were tested with L-lysine decarboxylase and by column chromatography. L-[1-14C]lysine was obtained in 60% yield with a steroisomeric purity of 95.1%, and D-[1-14C]lysine was obtained in a slightly higher yield with a steroisomeric purity of 97.5%.